Meyka Pro banner
Ainos, Inc.

Ainos, Inc. (AIMD) Stock Overview

Explore Ainos, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AIMD●NASDAQ
HealthcareBiotechnology
$1.09
$0.62(132.26%)
U.S. Market is Open · 13:07

Ainos, Inc. (AIMD)

Meyka AI Score

Z

Key Financials

Market Cap3.6M
P/E Ratio-0.18
EPS (TTM)$-2.52
ROE-2.17%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.81
3 Months$0.00
1 Year Target$2.43

AIMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Ainos, Inc. (NASDAQ: AIMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Ainos, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AIMD on the NASDAQ shows an RSI of 25.65, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $2.43 for the NASDAQ listing.

Key metrics behind Ainos, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.18 and a market capitalization of 3.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AIMD on the NASDAQ.

Price Performance (NASDAQ: AIMD)

1-Day Change
3.07%
5-Day Change
-23.59%
1-Month Change
-60.02%
3-Month Change
-67.32%
6-Month Change
-72.20%
Year-to-Date (YTD) Change
-70.51%
1-Year Change
-84.50%
3-Year Change
-96.93%
5-Year Change
-99.81%
All-Time (Max) Change
-99.16%

Contact Information

858 869 2986
3050 Post Oak Boulevard, Houston, TX, 77056

Company Facts

410 Employees
IPO DateJan 8, 2021
CountryUS
Actively Trading

Frequently Asked Questions